Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
43 Leser
Artikel bewerten:
(0)

Global Market for Laboratory-Developed Testing Report 2017: Breakdown by LDT Type & Analyte-Specific Reagent Use - Research and Markets

DUBLIN, June 22, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Laboratory-developed Testing: Technologies and Markets" report to their offering.

Research and Markets Logo

The report includes an overview of the global market for laboratory-developed testing. It provides analyses of global market trends, with data from 2014, 2015 and 2016, and projections of CAGRs through 2021. Coverage of different types of tests, including esoteric, public health, anatomic technology, genomic testing, mass spectrophotometry, and other new technologies are also included. Along with information on the industry's structure, with focuses on reagent manufacturers, reference laboratrories, academic medical centers, and trends in pricing and performance.

Report Scope

This report will focus on companies that rely on laboratory-developed testing for at least 10% of their revenue. This is meant to avoid focusing on companies and laboratories that occasionally offer laboratory-developed tests to deal with unique patient needs. This report will also focus on the suppliers of the analyte-specific reagents used within these laboratory-developed tests, as their contract manufacturing is key to the successful development of these tests. While various technologies will be highlighted with relation to their use in laboratory-developed testing, we will not explore the markets for these different technologies in depth.

Companies Mentioned

  • 23Andme
  • Arup Laboratories
  • Access Genetics
  • Asuragen
  • BD
  • Bioreference
  • Biotheranostics
  • Empire Genomics
  • Enzo Biochem
  • Genecentric Diagnostics
  • Genomic Health
  • IDT
  • Illumina
  • Labcorp
  • Luminex
  • Merck KGAA
  • Molecularhealth
  • Myriad Genetics
  • Neogenomics
  • Oxford Gene Technology
  • Quest Diagnostics
  • Rosetta Genomics
  • Thermo Fisher
  • Ventana Medical Systems Inc.

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Description of Laboratory-developed Tests

4: Uses of Laboratory Diagnostic Tests

5: Segments of Laboratory Diagnostic Tests

6: Market Breakdown by LDT Type

7: Market Breakdown by Analyte-specific Reagent Use

8: Patent Review/New Developments

9: Industry Structure

10: Government Regulations

11: Industry Issues

12: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/vp22j3/laboratorydevelop

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.